ANTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
AN2 Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$3.37−0.01 (-0.30%)
Close on Oct 19, 2026
- Market cap
- $150.84M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
-$38.11MFY2025